PEPTIDES (peptides containing -lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D 519/02; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N 15/00)
| Subclass | Title |
|---|---|
| 1/00 | General processes for the preparation of peptides |
| 1/02 | General processes for the preparation of peptides in solution |
| 1/04 | General processes for the preparation of peptides on carriers |
| 1/06 | General processes for the preparation of peptides using protecting groups or activating agents |
| 1/08 | General processes for the preparation of peptides using protecting groups or activating agents using activating agents |
| Patent # | Title | Filing Date | Issue Date | Patent Owner |
|---|---|---|---|---|
| 8,936,781 | Macrocyclic compounds as hepatitis C virus inhibitors | Apr 13, 10 | Jan 20, 15 | ENANTA PHARMACEUTICALS, INC. |
| 8,936,785 | scFv antibodies which pass epithelial and/or endothelial layers | Jul 10, 07 | Jan 20, 15 | ESBATECH, AN ALCON BIOMEDICAL RESEARCH UNIT LLC |
| 8,936,787 | Peptides promoting lipid efflux | Apr 14, 09 | Jan 20, 15 | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
| 8,936,790 | Injection paradigm for administration of botulinum toxins | Apr 16, 13 | Jan 20, 15 | ALLERGAN, INC. |
| 8,936,792 | exotoxin a with reduced immunogenicity | Sep 10, 10 | Jan 20, 15 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES |
| 8,936,807 | Use of the cathelicidin LL-37 and derivatives thereof for wound healing | Jul 09, 13 | Jan 20, 15 | LIPOPEPTIDE AB |
| 8,936,915 | Cleavage sensitive antibodies and methods of use thereof | Aug 17, 10 | Jan 20, 15 | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY |
| 8,936,917 | KEX2 cleavage regions of recombinant fusion proteins | Jul 03, 13 | Jan 20, 15 | DANISCO US INC. GENENCOR DIVISION |
| 8,936,918 | Yeast strain for the production of proteins with modified O-glycosylation | Feb 20, 12 | Jan 20, 15 | MERCK SHARP & DOHME CORP. |
| 8,936,930 | Red microalgae expressing exogenous polypeptides and methods of generating and utilizing same | Aug 04, 05 | Jan 20, 15 | BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY; MOR RESEARCH APPLICATIONS LTD.; |
| 8,937,038 | Composition containing peptide ligand that bonds with CXCR2 for treating infective and inflammatory diseases | Oct 19, 11 | Jan 20, 15 | RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY |
| 8,937,041 | Macrocyclic hepatitis C serine protease inhibitors | Dec 29, 11 | Jan 20, 15 | ABBVIE INC. |
| 8,937,042 | Pharmaceutical compositions comprising GLP-1 peptides or extendin-4 and a basal insulin peptide | Nov 14, 08 | Jan 20, 15 | NOVO NORDISK A/S |
| 8,937,044 | Process for the synchronization of ovulation for timed breeding without heat detection | Nov 27, 12 | Jan 20, 15 | THORN BIOSCIENCE LLC |
| 8,937,045 | Liquid formulations of tumor necrosis factor-binding proteins | Feb 11, 04 | Jan 20, 15 | ARES TRADING SA |
| 8,937,046 | Modulating the alternative complement pathway | Sep 22, 09 | Jan 20, 15 | THE REGENTS OF THE UNIVERSITY OF COLORADO A BODY CORPORATE |
| 8,937,047 | Biokinetics of fast-clearing polypeptides | Dec 19, 07 | Jan 20, 15 | GENERAL ELECTRIC COMPANY |
| 8,937,048 | Anti-angiogenic compounds | Aug 27, 12 | Jan 20, 15 | COVX TECHNOLOGIES IRELAND, LIMITED |
| 8,937,080 | Pyrimidine substituted macrocyclic HCV inhibitors | Feb 08, 08 | Jan 20, 15 | MEDIVIR AB; JANSSEN R&D IRELAND; |
| 8,937,150 | Anti-viral compounds | May 04, 11 | Jan 20, 15 | ABBVIE INC. |
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2015/0023,871 | COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR | Sep 29, 14 | Jan 22, 15 | GENENTECH INC. |
| 2015/0023,872 | HOMING AGENTS | May 05, 14 | Jan 22, 15 | Not available |
| 2015/0023,918 | LONG ACTING PROTEINS AND PEPTIDES AND METHODS OF MAKING AND USING THE SAME | Nov 25, 13 | Jan 22, 15 | BOLDER BIOTECHNOLOGY INC. |
| 2015/0023,920 | NOVEL COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING CANCER METASTASIS | Mar 13, 13 | Jan 22, 15 | DREXEL UNIVERSITY |
| 2015/0023,924 | VARIANT AAV AND COMPOSITIONS, METHODS AND USES FOR GENE TRANSFER TO CELLS, ORGANS AND TISSUES | Jul 22, 14 | Jan 22, 15 | Not available |
| 2015/0023,932 | ENGINEERED PEPTIDE (EP)-DIRECTED PROTEIN INTERCELLULAR DELIVERY SYSTEM AND USES THEREOF | Jul 17, 13 | Jan 22, 15 | Not available |
| 2015/0023,949 | COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER | Mar 05, 13 | Jan 22, 15 | Not available |
| 2015/0023,951 | ANTI-VEGF ANTIBODIES | Feb 03, 14 | Jan 22, 15 | GENENTECH, INC. |
| 2015/0023,952 | ANTI-ADDL MONOCLONAL ANTIBODY AND USES THEREOF | Jul 09, 14 | Jan 22, 15 | Not available |
| 2015/0023,956 | METHODS AND COMPOSITIONS FOR INCREASING ENZYME ACTIVITY IN THE CNS | May 19, 14 | Jan 22, 15 | ARMAGEN TECHNOLOGIES, INC. |
| 2015/0023,957 | SAA DOMAIN-SPECIFIC ANTIBODIES AND PEPTIDE ANTAGONISTS AND USE THEREOF TO TREAT INFLAMMATORY DISEASES | Jul 09, 14 | Jan 22, 15 | THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH |
| 2015/0023,958 | FUSION POLYPEPTIDE INHIBITING VEGF-C, VEGF-D AND/OR ANGIOPOIETIN-2, AND USE THEREOF | Jul 21, 14 | Jan 22, 15 | Not available |
| 2015/0023,959 | CHIMERIC FACTOR VIII POLYPEPTIDES AND USES THEREOF | Jan 12, 13 | Jan 22, 15 | BIOGEN IDEC MA INC. |
| 2015/0023,960 | Compositions and Methods of Use for Treating Metabolic Disorders | Mar 08, 13 | Jan 22, 15 | Not available |
| 2015/0023,961 | METHODS OF MODULATING IMMUNOLOGICAL RESPONSES BY ADMINISTERING TRUNCATED BAFF RECEPTORS | Jul 28, 14 | Jan 22, 15 | BIOGEN IDEC MA INC. |
| 2015/0023,963 | METHOD FOR THE PRODUCTION OF VARIABLE DOMAINS | Jun 20, 14 | Jan 22, 15 | ABLYNX N.V. |
| 2015/0023,964 | FcgammaRIIB-Specific Antibodies and Methods of Use Thereof | Jul 15, 14 | Jan 22, 15 | MACROGENICS, INC. |
| 2015/0023,965 | METHODS OF TREATING UROTHELIAL CARCINOMA | Jul 16, 14 | Jan 22, 15 | FOUNDATION MEDICINE, INC. |
| 2015/0023,966 | COMBINATION THERAPIES USING ANTI-PSEUDOMONAS PSL AND PCRV BINDING MOLECULES | Nov 06, 12 | Jan 22, 15 | Not available |
| 2015/0023,967 | BINDING MOLECULES FOR BCMA AND CD3 | Nov 15, 12 | Jan 22, 15 | Not available |
